OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
5.00
+0.09 (1.83%)
Mar 19, 2025, 4:00 PM EDT - Market closed
OnKure Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -52.67 | -35.31 | -29.51 |
| Depreciation & Amortization | 0.66 | 0.56 | 0.39 |
| Other Amortization | 0.14 | - | - |
| Loss (Gain) From Sale of Investments | 0.05 | - | - |
| Stock-Based Compensation | 4.53 | 0.2 | 0.05 |
| Other Operating Activities | 0.12 | - | - |
| Change in Accounts Payable | -5.93 | 1.71 | 2.65 |
| Change in Other Net Operating Assets | 1.98 | -1.71 | -0.53 |
| Operating Cash Flow | -51.12 | -34.55 | -26.95 |
| Capital Expenditures | -0.05 | -0.25 | -1.13 |
| Investment in Securities | 15.93 | - | - |
| Investing Cash Flow | 15.87 | -0.25 | -1.13 |
| Long-Term Debt Issued | 6 | - | - |
| Net Debt Issued (Repaid) | 6 | - | - |
| Issuance of Common Stock | 58.91 | 0.07 | 0.34 |
| Other Financing Activities | 51.22 | -0.72 | -1.38 |
| Financing Cash Flow | 116.13 | 53.13 | 26.47 |
| Net Cash Flow | 80.89 | 18.33 | -1.62 |
| Free Cash Flow | -51.17 | -34.79 | -28.09 |
| Free Cash Flow Per Share | -14.84 | -122.59 | - |
| Levered Free Cash Flow | -23.71 | -22.69 | - |
| Unlevered Free Cash Flow | -23.76 | -22.69 | - |
| Change in Net Working Capital | -4.57 | 0.12 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.